If you cannot read this message, click here.
     DDNews Top 5 Cancer Stories
       May 2016
From our April 2016 issue:
By Lori Lesko, DDNews Contributing Editor
Company identifies binding partner for CGEN-15029 and moves closer to IND filing
From our April 2016 issue:
By Jeffrey Bouley, DDNews Chief Editor
University of York's unique collection of PDX models to be applied to drug development
From our April 2016 issue:
By Nicola McCarthy & Jonathan Moore of Horizon Discovery
Cancer therapy is fast approaching a clinical crossroads: to treat a cancer patient with an approach based on stimulating an immune response, or to target the cancer cells directly with cytotoxic or a targeted therapy?
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Managing Editor
Heptares, Kymab ink strategic collaboration to target GPCRs in immuno-oncology
From DDNews Online:
By Jeffrey Bouley, DDNews Chief Editor
License agreement with Yale and identification of lung cancer markers cap recent activities
Facebook Facebook
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600 | Fax: 440-331-7563
©2016 Old River Publications LLC. All Rights Reserved.
Web site designed and managed by Offenberger & White, Inc..
Please note that this email was sent from an unmonitored address, so please do not reply directly to this email.
If you no longer wish to receive DDNews mailings, please unsubscribe here.